P3.12.64 Frontline Treatment Duration in MET-Amplified NSCLC After Third-Generation EGFR-TKI Failure: SACHI Study Insights
Year: 2025
Type: article
Source: Journal of Thoracic Oncology
Authors: L. Chen, S. Lu, J. Wang, N. Yang, D. Lv, L. Wu, X. Li, L. Sun, Y. Yu, B. Jin, L. Yang, Y. Guo, H. Xu, T. Yi, A. Zeng, X. Dong, J. Chen, Z. Wang, H. Niu, Y. Cheng, P. Pan, P. Deng, H. Pan, X. Min, J. Bai, L. Liu, T. Zhang, J. Li, F. Ye, X. Liu, J. Shi, J. Liu, Q. Guo, W. Yang, J. Tang, S. Cang, O. Jiang, J. Fang, G. Yu, L. Wang, X. Zhuang, X. Wang, J. Yu, H. Yan, X. Luo, X. Guo, Y. Ren, S. Fan, M.M. Shi, W. Su
Institutions: Central South University, Zhengzhou University, Hunan Cancer Hospital, Henan Cancer Hospital, Shanghai Jiao Tong University, Shanghai Chest Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Second People Hospital of Hunan, ShenZhen People’s Hospital, Wenzhou Medical University, First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Nanchang University, First Hospital of China Medical University, Sun Yat-sen University, The First Affiliated Hospital, Sun Yat-sen University, Fujian Provincial Cancer Hospital, Xiangyang Central Hospital, Guangxi Medical University, Tumor Hospital of Guangxi Medical University, Wuhan Union Hospital, Huazhong University of Science and Technology, First Affiliated Hospital of Xinxiang Medical University, Henan Medical University, Jilin Province Tumor Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415520277